323 related articles for article (PubMed ID: 17690113)
21. Cancer phenotype correlates with constitutional TP53 genotype in families with the Li-Fraumeni syndrome.
Birch JM; Blair V; Kelsey AM; Evans DG; Harris M; Tricker KJ; Varley JM
Oncogene; 1998 Sep; 17(9):1061-8. PubMed ID: 9764816
[TBL] [Abstract][Full Text] [Related]
22. The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families.
Achatz MI; Olivier M; Le Calvez F; Martel-Planche G; Lopes A; Rossi BM; Ashton-Prolla P; Giugliani R; Palmero EI; Vargas FR; Da Rocha JC; Vettore AL; Hainaut P
Cancer Lett; 2007 Jan; 245(1-2):96-102. PubMed ID: 16494995
[TBL] [Abstract][Full Text] [Related]
23. Inherited p53 gene mutations in breast cancer.
Sidransky D; Tokino T; Helzlsouer K; Zehnbauer B; Rausch G; Shelton B; Prestigiacomo L; Vogelstein B; Davidson N
Cancer Res; 1992 May; 52(10):2984-6. PubMed ID: 1581912
[TBL] [Abstract][Full Text] [Related]
24. Predominantly tumor-limited expression of a mutant allele in a Japanese family carrying a germline p53 mutation.
Horio Y; Suzuki H; Ueda R; Koshikawa T; Sugiura T; Ariyoshi Y; Shimokata K; Takahashi T; Takahashi T
Oncogene; 1994 Apr; 9(4):1231-5. PubMed ID: 8134126
[TBL] [Abstract][Full Text] [Related]
25. Infrequent germ-line mutation of the E-cadherin gene in Japanese familial gastric cancer kindreds.
Iida S; Akiyama Y; Ichikawa W; Yamashita T; Nomizu T; Nihei Z; Sugihara K; Yuasa Y
Clin Cancer Res; 1999 Jun; 5(6):1445-7. PubMed ID: 10389930
[TBL] [Abstract][Full Text] [Related]
26. Gastric cancer: new genetic developments.
Lynch HT; Grady W; Suriano G; Huntsman D
J Surg Oncol; 2005 Jun; 90(3):114-33; discussion 133. PubMed ID: 15895459
[TBL] [Abstract][Full Text] [Related]
27. Germ-line exclusion of a single p53 allele by premature termination of translation in a Li-Fraumeni syndrome family.
Stolzenberg MC; Brugières L; Gardes M; Dessarps-Freichey F; Chompret A; Bressac B; Lenoir G; Bonaïti-Pellié C; Lemerle J; Feunteun J
Oncogene; 1994 Oct; 9(10):2799-804. PubMed ID: 8084585
[TBL] [Abstract][Full Text] [Related]
28. p53 compound heterozygosity in a severely affected child with Li-Fraumeni syndrome.
Quesnel S; Verselis S; Portwine C; Garber J; White M; Feunteun J; Malkin D; Li FP
Oncogene; 1999 Jul; 18(27):3970-8. PubMed ID: 10435620
[TBL] [Abstract][Full Text] [Related]
29. Germ-line mutations of TP53 in Li-Fraumeni families: an extended study of 39 families.
Varley JM; McGown G; Thorncroft M; Santibanez-Koref MF; Kelsey AM; Tricker KJ; Evans DG; Birch JM
Cancer Res; 1997 Aug; 57(15):3245-52. PubMed ID: 9242456
[TBL] [Abstract][Full Text] [Related]
30. Characterization of the oligomerization defects of two p53 mutants found in families with Li-Fraumeni and Li-Fraumeni-like syndrome.
Davison TS; Yin P; Nie E; Kay C; Arrowsmith CH
Oncogene; 1998 Aug; 17(5):651-6. PubMed ID: 9704931
[TBL] [Abstract][Full Text] [Related]
31. Younger age of cancer initiation is associated with shorter telomere length in Li-Fraumeni syndrome.
Tabori U; Nanda S; Druker H; Lees J; Malkin D
Cancer Res; 2007 Feb; 67(4):1415-8. PubMed ID: 17308077
[TBL] [Abstract][Full Text] [Related]
32. Identification of a novel p53 in-frame deletion in a Li-Fraumeni-like family.
Schiffman JD; Chun N; Fisher PG; Dahl GV; Ford JM; Eggerding FA
Pediatr Blood Cancer; 2008 Apr; 50(4):914-6. PubMed ID: 17554785
[TBL] [Abstract][Full Text] [Related]
33. [Somatic mutations of the P53 gene in stomach cancer].
Beliavskaia VA; Vardosanidze KV; Oreshkova SF; Blinov AG; Ternovoĭ VA; Blinov VM; Cherdyntseva NV; Voevoda MI
Vopr Onkol; 2010; 56(2):156-61. PubMed ID: 20552890
[TBL] [Abstract][Full Text] [Related]
34. Identification of a novel germ line variant hotspot mutant p53-R175L in pediatric adrenal cortical carcinoma.
West AN; Ribeiro RC; Jenkins J; Rodriguez-Galindo C; Figueiredo BC; Kriwacki R; Zambetti GP
Cancer Res; 2006 May; 66(10):5056-62. PubMed ID: 16707427
[TBL] [Abstract][Full Text] [Related]
35. Aberrant p53 protein expression and function in a panel of hematopoietic cell lines with different p53 mutations.
Kamihira S; Terada C; Sasaki D; Yanagihara K; Tsukasaki K; Hasegawa H; Yamada Y
Eur J Haematol; 2009 Apr; 82(4):301-7. PubMed ID: 19220422
[TBL] [Abstract][Full Text] [Related]
36. p53 mosaicism with an exon 8 germline mutation in the founder of a cancer-prone pedigree.
Kovar H; Auinger A; Jug G; Müller T; Pillwein K
Oncogene; 1992 Nov; 7(11):2169-73. PubMed ID: 1359493
[TBL] [Abstract][Full Text] [Related]
37. [Li-Fraumeni syndrome and germ-line mutations of the p53 gene].
Leblanc T; Soussi T
Arch Pediatr; 1994 Jan; 1(1):61-70. PubMed ID: 8087224
[TBL] [Abstract][Full Text] [Related]
38. Identification of novel TP53 mutations in familial and sporadic cancer cases of German and Swiss origin.
Bendig I; Mohr N; Kramer F; Weber BH
Cancer Genet Cytogenet; 2004 Oct; 154(1):22-6. PubMed ID: 15381368
[TBL] [Abstract][Full Text] [Related]
39. High frequency of de novo mutations in Li-Fraumeni syndrome.
Gonzalez KD; Buzin CH; Noltner KA; Gu D; Li W; Malkin D; Sommer SS
J Med Genet; 2009 Oct; 46(10):689-93. PubMed ID: 19556618
[TBL] [Abstract][Full Text] [Related]
40. A functionally inactive p53 Li-Fraumeni syndrome mutant.
Hao M; Finlay CA; Lozano G
Oncogene; 1993 Feb; 8(2):299-306. PubMed ID: 8426739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]